Javascript must be enabled to continue!
Liposomal Drug Delivery of Blumea lacera Leaf Extract: In-Vivo Hepatoprotective Effects
View through CrossRef
Background: Blumea lacera (B. lacera) is a herbaceous plant commonly found in south-east Asia. It shows significant therapeutic activities against various diseases. The objectives of this study were to evaluate hepatoprotective effects of Blumea lacera leaf extract and also to investigate the comparative effectiveness between a liposomal preparation and a suspension of B. lacera leaf extract against carbon tetrachloride (CCl4)-induced liver damage. Methods: B. lacera leaf extract was characterized using a GC-MS method. A liposomal preparation of B. lacera leaf extract was developed using an ethanol injection method and characterized using dynamic light scattering (DLS) and electronic microscopic systems. The hepatoprotective effects of B. lacera leaf extracts and its liposomal preparation were investigated using CCl4-induced liver damage in Long Evan rats. Results: GC-MS data showed the presence of different components (e.g., phytol) in the B. lacera leaf extract. DLS and microscopic data showed that a liposomal preparation of B. lacera leaf extracts was in the nano size range. In vivo study results showed that liposomal preparation and a suspension of B. lacera leaf extract normalized liver biochemical parameters, enzymes and oxidative stress markers which were elevated due to CCl4 administration. However, a liposomal formulation of B. lacera leaf extract showed significantly better hepatoprotective effects compared to a suspension of leaf extract. In addition, histopathological evaluation showed that B. lacera leaf extract and its liposomal preparation treatments decreased the extent of CCl4-induced liver inflammations. Conclusion: Results demonstrated that B. lacera leaf extract was effective against CCl4-induced liver injury possibly due to the presence of components such as phytol. A liposomal preparation exhibited significantly better activity compared to a B. lacera suspension, probably due to improved bioavailability and stability of the leaf extract.
Title: Liposomal Drug Delivery of Blumea lacera Leaf Extract: In-Vivo Hepatoprotective Effects
Description:
Background: Blumea lacera (B.
lacera) is a herbaceous plant commonly found in south-east Asia.
It shows significant therapeutic activities against various diseases.
The objectives of this study were to evaluate hepatoprotective effects of Blumea lacera leaf extract and also to investigate the comparative effectiveness between a liposomal preparation and a suspension of B.
lacera leaf extract against carbon tetrachloride (CCl4)-induced liver damage.
Methods: B.
lacera leaf extract was characterized using a GC-MS method.
A liposomal preparation of B.
lacera leaf extract was developed using an ethanol injection method and characterized using dynamic light scattering (DLS) and electronic microscopic systems.
The hepatoprotective effects of B.
lacera leaf extracts and its liposomal preparation were investigated using CCl4-induced liver damage in Long Evan rats.
Results: GC-MS data showed the presence of different components (e.
g.
, phytol) in the B.
lacera leaf extract.
DLS and microscopic data showed that a liposomal preparation of B.
lacera leaf extracts was in the nano size range.
In vivo study results showed that liposomal preparation and a suspension of B.
lacera leaf extract normalized liver biochemical parameters, enzymes and oxidative stress markers which were elevated due to CCl4 administration.
However, a liposomal formulation of B.
lacera leaf extract showed significantly better hepatoprotective effects compared to a suspension of leaf extract.
In addition, histopathological evaluation showed that B.
lacera leaf extract and its liposomal preparation treatments decreased the extent of CCl4-induced liver inflammations.
Conclusion: Results demonstrated that B.
lacera leaf extract was effective against CCl4-induced liver injury possibly due to the presence of components such as phytol.
A liposomal preparation exhibited significantly better activity compared to a B.
lacera suspension, probably due to improved bioavailability and stability of the leaf extract.
Related Results
Assessment of Antioxidant and Antineoplastic Activities Blumea lacera (Burn. F) Leaves
Assessment of Antioxidant and Antineoplastic Activities Blumea lacera (Burn. F) Leaves
Abstract: Blumea lacera (Burn. f.) DC. (Family: Asteraceae) is an important member of Bangladeshi natural plant resource and it is an herbaceous weed locally known as Kukursunga. D...
Blumea lacera Plant Poisoning in Cattle; Epidemiology and Management
Blumea lacera Plant Poisoning in Cattle; Epidemiology and Management
Plant poisoning in grazing animals is more common in Bangladesh, especially during the scarcity period. The present study was undertaken to find out the epidemiology of Blumea lace...
Hepatoprotective activity of Ammi majus on CCL4 Induced Albino Mice
Hepatoprotective activity of Ammi majus on CCL4 Induced Albino Mice
This study was amid to evaluate the possible protective effects of the water and alcoholic extract of Ammi majus seeds against liver damage induced in mice by CCL4. The plant was c...
Liposomal drug delivery of Aphanamixis polystachya leaf extracts and its neurobehavioral activity in mice model
Liposomal drug delivery of Aphanamixis polystachya leaf extracts and its neurobehavioral activity in mice model
AbstractNeurodegenerative diseases (Alzheimer’s, Parkinson’s etc.) causes brain cell damage leading to dementia. The major restriction remains in delivering drug to the central ner...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND
As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis
A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis
Background:
Treatment of post-kala-azar dermal leishmaniasis cases is of paramount importance for kala-azar elimination; however, limited treatment regimens are available as of now...
To Study Analgesic, Hypoglycemic and Hepatoprotective Activity of Moringa olefera Leaf Extract in Albino Wistar Rats
To Study Analgesic, Hypoglycemic and Hepatoprotective Activity of Moringa olefera Leaf Extract in Albino Wistar Rats
Introduction: Moringa oleifera is widely found in Asian subcontinent and it has been used as an Analgesic, Hypoglycemic and hepatoprotective in Indian folklore medicine. In this st...
Wound Healing Effects of Liposomal Nanocurcumin and PL Pro Nanocurcumin on Thermal Burn and Skin Ulcer
Wound Healing Effects of Liposomal Nanocurcumin and PL Pro Nanocurcumin on Thermal Burn and Skin Ulcer
Background
Burn injuries and skin ulcers are important health problems resulting in physical and psychological scars and chronic disabilities. This study investigated the wo...

